Abstract:We have previously shown that dysregulation of miR-21 functioned as an oncomiR in breast cancer. The aim of the present study was to elucidate the mechanisms by which miR-21 regulate breast tumor migration and invasion. We applied pathway analysis on genome microarray data and target-predicting algorithms for miR-21 target screening, and used luciferase reporting assay to confirm the direct target. Thereafter, we investigated the function of the target gene phosphoinositide-3-kinase, regulatory subunit 1 (α) (PIK3R1), and detected PIK3R1 coding protein (p85α) by immunohistochemistry and miR-21 by RT-qPCR on 320 archival paraffin-embedded tissues of breast cancer to evaluate the correlation of their expression with prognosis. First, we found that PIK3R1 suppressed growth, invasiveness, and metastatic properties of breast cancer cells. Next, we identified the PIK3R1 as a direct target of miR-21 and showed that it was negatively regulated by miR-21. Furthermore, we demonstrated that p85α overexpression phenocopied the suppression effects of antimiR-21 on breast cancer cell growth, migration and invasion, indicating its tumor suppressor role in breast cancer. On the contrary, PIK3R1 knockdown abrogated antimiR‑21-induced effect on breast cancer cells. Notably, antimiR-21 induction increased p85α, accompanied by decreased p-AKT level. Besides, antimiR-21/PIK3R1-induced suppression of invasiveness in breast cancer cells was mediated by reversing epithelial-mesenchymal transition (EMT). p85α downregulation was found in 25 (7.8%) of the 320 breast cancer patients, and was associated with inferior 5-year disease-free survival (DFS) and overall survival (OS). Taken together, we provide novel evidence that miR-21 knockdown suppresses cell growth, migration and invasion partly by inhibiting PI3K/AKT activation via direct targeting PIK3R1 and reversing EMT in breast cancer. p85α downregulation defined a specific subgroup of breast cancer with shorter 5-year DFS and OS, which may require more aggressive treatment.

BRCA1 overexpression attenuates breast cancer cell growth and migration by regulating the pyruvate kinase M2-mediated Warburg effect via the PI3K/AKT signaling pathway

Abstract #4440: BRCA1 Modulates Malignant Cell Behavior, the Expression of Survivin and Chemosensitivity in Human Breast Cancer Cells

MUC1 Promotes Glycolysis Through Inhibiting BRCA1 Expression in Pancreatic Cancer.

Negative Regulation Of Akt Activation By Brca1

PFKP is Transcriptionally Repressed by BRCA1/ZBRK1 and Predicts Prognosis in Breast Cancer.

Data from Absence of the Full-Length Breast Cancer–Associated Gene-1 Leads to Increased Expression of Insulin-Like Growth Factor Signaling Axis Members

Regulation of the estrogen-inducible gene expression profile by the breast cancer susceptibility gene BRCA1.

BRCA1 regulates gene expression for orderly mitotic progression.

Brca2 Suppresses Cell Proliferation Via Stabilizing Mage-D1

TPI1 activates the PI3K/AKT/mTOR signaling pathway to induce breast cancer progression by stabilizing CDCA5

Anti-Warburg effect by targeting HRD1-PFKP pathway may inhibit breast cancer progression

Growth Factor Signaling Pathways Modulate Brca1 Repression of Estrogen Receptor-Alpha Activity

The Apoptotic Resistance of BRCA1-Deficient Ovarian Cancer Cells is Mediated by cAMP

PKM2 Promotes Glucose Metabolism Through a Let-7A-5p/stat3/hnrnp-a1 Regulatory Feedback Loop in Breast Cancer Cells

Synergistic Therapeutic Effect of Cisplatin and Phosphatidylinositol 3-Kinase (PI3K) Inhibitors in Cancer Growth and Metastasis of Brca1 Mutant Tumors.

BRCA1 negatively regulates miR-146a and inhibits its tumor promoting functions in breast cancer cells

Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention

PIK3R1 Targeting by Mir-21 Suppresses Tumor Cell Migration and Invasion by Reducing PI3K/AKT Signaling and Reversing EMT, and Predicts Clinical Outcome of Breast Cancer

Loss of Function of BRCA1 Promotes EMT in Mammary Tumors Through Activation of TGFβR2 Signaling Pathway

PKM2–c-Myc–Survivin Cascade Regulates the Cell Proliferation, Migration, and Tamoxifen Resistance in Breast Cancer

BRCA1 shifts p53-mediated cellular outcomes towards irreversible growth arrest